Skip to main content

MedImmune, Inc.

MedImmune, Inc.
MedImmune was a subsidiary of AstraZeneca. In February 2019 the MedImmune name and branding was discontinued in favor of AstraZeneca.
Website: https://www.astrazeneca.com/Careers: https://careers.astrazeneca.com

Latest News

Drugs Associated with MedImmune, Inc.

MedImmune, Inc. manufactures, markets and/or distributes more than 3 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Brand/Generic Name Reviews Rating
FluMist Quadrivalent
Generic name: influenza virus vaccine, live, trivalent
Drug class: viral vaccines
1 review 1.0 / 10
Lumoxiti
Generic name: moxetumomab pasudotox
Drug class: miscellaneous antineoplastics
Synagis
Generic name: palivizumab
Drug class: immune globulins
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Discontinued Drugs

Brand/Generic Name Reviews Rating
Neutrexin
Generic name: trimetrexate
Drug class: miscellaneous antibiotics
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).